Roche, Clovis Co-developing Companion Diagnostic for EGFR Mutations

The assay will be for CO-1686, which is currently in pre-clinical development for advanced non-small cell lung cancer patients.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.